HSC Technology (ASX: HSC) gains TGA certification for CardiacSense solution

2 min read | May 09, 2022 03:48 PM AEST | By Aditi Sarkar

HSC Technology (ASX: HSC) gains TGA certification for CardiacSense solution — Image source: © Prykhodov | Megapixl.com

Highlights

HSC receives TGA certification for CardiacSense wearable

The CardiacSense solution is a watch designed for continuous measurement of heart rate and arrhythmias at ECG-level accuracy

HSC is the first and only company to receive TGA certification for continuous PPG wristband monitoring

HSC has a material market prospect as Australia has an estimated 4 million people with hypertension

Technology enabled care solutions provider HSC Technology Group Ltd (ASX:HSC) has hit an important milestone. The company has received Therapeutic Goods Administration (TGA) certification for its CardiacSense wearable, marking the onset of its commercialisation.

HSC provides a range of technology-enabled care solutions to aged people and people with disabilities. The company’s Software as a Service (SaaS) data analytics platform Talius Smart Care combines smart sensors with AI machine learning (powered by CSIRO) that delivers automated actions.

HSC is the first and only company to receive TGA certification for continuous PPG wristband monitoring. The approval will allow HSC to provide proactive health monitoring to the Australian and New Zealand markets.

Effective and persistent monitoring

The CardiacSense solution is a watch designed to measure heart rate and arrhythmias at ECG-level accuracy continuously. Data of CardiacSense is integrated into the HSC Talius Platform to enable emergency response and remote patient monitoring, providing a crucial element for an end-to-end solution of 24hr support.

It avoids the need to implant invasive cardiac monitors and enables continuous long-term, accurate and comfortable monitoring of patients with arrhythmias.

Data source: company update

HSC Technology Group is the exclusive partner with CardiacSense in Australia and New Zealand. CardiacSense, a digital health company, has also launched clinical trials to receive regulatory certification for other vital signs, including continuous respiratory rate, core temperature, oxygen saturation, blood pressure and other arrhythmias.

According to Mr Graham Russell, Managing Director of HSC technology, HSC has a material market prospect as Australia has an estimated 4 million people with hypertension.

HSC has received great interest from the cardiology sector, reflecting that CardiacSense is also the first cost-effective post-treatment solution that will enable ongoing and uninterrupted monitoring for clients and the prospect of providing better lasting health outcomes.

Also read: Why did HSC Technology (ASX:HSC) shares close 12.5% higher today?

HSC shares traded at AU$0.2 on 9 May 2022.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.